OncoTherapy Science Overview

  • Status
  • Public
  • Employees
  • 71
Employees
  • Stock Symbol
  • 4564
Stock Symbol
  • Share Price
  • $1.01
  • (As of Monday Closing)

OncoTherapy Science General Information

Description

OncoTherapy Science Inc focuses on cancer-related cells and genes and develops cancer therapy products which include low molecular drugs, antibody drugs, cancer peptide vaccine, and diagnostic medicine in Japan.

Contact Information

Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Stock Exchange
TKS
Primary Office
  • Kanagawa
  • Japan
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

OncoTherapy Science Stock Performance

(As of Monday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$1.01 $1.00 $0.81 - $2.12 $179M 176M 1.72M -$0.09

OncoTherapy Science Financials Summary

In Thousands,
USD
TTM 31-Dec-2020 FY 2020 31-Mar-2020 FY 2019 31-Mar-2019 FY 2018 31-Mar-2018
EV 161,327 60,109 136,378 229,977
Revenue 2,948 2,908 2,531 1,906
EBITDA (20,215) (25,286) (25,004)
Net Income (15,410) (20,588) (26,471) (25,720)
Total Assets 36,163 47,080 48,405 75,483
Total Debt 0 0 0 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

OncoTherapy Science Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial